Given that cancer‐associated transcriptional changes in CLD do not appear to be underpinned by genomic changes frequently observed in HCC, we asked whether epigenetic alterations may help explain the transition towards HCC. Here, SLC26A3 is linked to hepatocellular carcinoma.